{
  "ptid_time": "019_S_4477_2014-02-06",
  "img_path": "/data/qiuhui/data/adni/images/019_S_4477/2014-02-06/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,693 mm³, 0.7% below the reference mean. With a Z-score of -0.02 (49.2th percentile), this represents normal volume ; whole brain volume measures 756,341 mm³, 18.5% below the reference mean. With a Z-score of -2.22 (1.3th percentile), this represents significant atrophy; entorhinal cortex volume measures 1,843 mm³, 46.8% below the reference mean. With a Z-score of -2.53 (0.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 10,499 mm³, 34.8% below the reference mean. With a Z-score of -2.62 (0.4th percentile), this represents significant atrophy; middle temporal gyrus volume measures 10,490 mm³, 41.8% below the reference mean. With a Z-score of -3.72 (0.0th percentile), this represents profound atrophy. ",
  "text_data": "Age is 84.1 years. Gender is Female. Education: 14 years. MMSE: 18.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.65 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant atrophy in multiple brain regions (whole brain, entorhinal cortex, fusiform gyrus, and profound atrophy in the middle temporal gyrus), along with a profoundly elevated AV45 (amyloid PET) and an MMSE score of 18, indicating cognitive impairment. These findings, combined with APOE4 positivity and advanced age, strongly suggest neurodegenerative disease.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease given the amyloid burden and atrophy pattern).  \n\n**Confidence:** **High** (due to clear structural and biomarker evidence of neurodegeneration and cognitive impairment).",
  "timestamp": "2025-07-26T01:06:24.980853"
}